Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

ClinicalTrials.gov ID: NCT04611152

Public ClinicalTrials.gov record NCT04611152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Visual Impairment Secondary to Treatment-naïve Diabetic Macular Edema (DME)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3 study will evaluate the efficacy, durability, and safety of KSI-301 compared to aflibercept in participants with treatment-naïve DME.

Study identification

NCT ID
NCT04611152
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kodiak Sciences Inc
Industry
Enrollment
460 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2020 (Actual)
Primary completion
May 11, 2023 (Actual)
Completion
Aug 31, 2023 (Actual)
Last update posted
Aug 22, 2024

2020 – 2023

United States locations

U.S. sites
48
U.S. states
21
U.S. cities
47
Facility City State ZIP Site status
UCSD Jacobs Retina Center La Jolla California 92037 —
Retina Consultants of Southern California Redlands California 92374 —
California Retina Consultants Santa Maria California 93454 —
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance California 90502 —
Colorado Retina Associates PC Lakewood Colorado 80228 —
Conneticut Eye Consultants Danbury Connecticut 06810 —
Retina Group of Florida Boca Raton Florida 33431 —
Blue Ocean Clinical Research Clearwater Florida 33761 —
Vitreo Retinal Associates Gainesville Florida 32607 —
Florida Retina Consultants Lakeland Florida 33805 —
Florida Eye Associates Melbourne Florida 32901 —
Florida Retina Institute Orlando Florida 32806 —
Retina Specialty Institute Pensacola Florida 32503 —
Retina Associates of Florida Tampa Florida 33609 —
Retina Vitreous Associates of Florida Tampa Florida 33617 —
Center for Retina & Macular Disease Winter Haven Florida 33880 —
Springfield Clinic LLP Springfield Illinois 62703 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
Retina Associates PA Lenexa Kansas 66215 —
Vitreo Retinal Consultants and Surgeons Wichita Kansas 67214 —
Retina Associates of Kentucky Lexington Kentucky 40509 —
Cumberland Valley Retina Consultants PC Hagerstown Maryland 21740 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Foundation for Vision Research Grand Rapids Michigan 49525 —
The Retina Center of New Jersey Bloomfield New Jersey 07017 —
NJ Retina Teaneck New Jersey 07605 —
Charlotte Eye Ear Nose & Throat Associates, P.A. Charlotte North Carolina 28210 —
Retina Northwest Portland Oregon 97210 —
Cascade Medical Research Institute Springfield Oregon 97477 —
MidAtlantic Retina Philadelphia Pennsylvania 19107 —
Retina Research of Beaufort Beaufort South Carolina 29902 —
Charleston Neuroscience Institute - West Ashley Charleston South Carolina 29414 —
Pametto Retina Center Florence South Carolina 29501 —
Charleston Neuroscience Institute Ladson South Carolina 29456 —
Palmetto Retina Center West Columbia South Carolina 29169 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Charles Retina Institute Germantown Tennessee 38138 —
Tennessee Retina PC Nashville Tennessee 37203 —
Southwest Retina Specialists Amarillo Texas 79106 —
Texas Retina Associates Arlington Texas 76012 —
Austin Retina Associates Austin Texas 78705 —
Star Retina Burleson Texas 76028 —
Retina Consultants of Texas Houston Texas 77030 —
Retina Consultants of San Antonio San Antonio Texas 78240 —
Strategic Clinical Research Group, LLC Willow Park Texas 76087 —
Piedmont Eye Center Lynchburg Virginia 24502 —
Retina Center Northwest Silverdale Washington 98383 —
Spokane Eye Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04611152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 22, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04611152 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →